Galaxy Digital Inc. (NASDAQ: GLXY) (TSX: GLXY) (the “Company” or “GDI”) today released financial results for the three and six months ended June 30, 2025. In this press release, a reference to “Galaxy”, “we”, “our” and similar words refer to GDI, its subsidiaries and affiliates, and Galaxy Digital Holdings LP (the “Partnership” or “GDH LP”), […]

— Expansion into Djibouti adds toQuarterhill's growing portfolio in East Africa, demonstrating the Company's ability to address diverse transportation needs in the region. — Repeat orders from Thailand and South Korea reinforce proven reliability ofQuarterhill's weigh-in-motion systems. Quarterhill Inc. (“Quarterhill” or the “Company”) (TSX: QTRH) (OTCQX: QTRHF), a leading global provider of intelligent transportation system

The non-recourse construction loan had a 2-year term, with two 6-month extension options and achieved an 86% loan-to-cost. Trinity Street Capital Partners (TSCP) (www.trinitystreetcp.com), a real estate finance company, announces the origination of a $61MM non-recourse construction loan for the development of a 250 unit, class A, market rate multifamily property located in Charleston, SC.

Streamlining Vision Processing and AI Application Development for Industrial, Automotive, Defense, and Smart Retail Markets DeGirum®, a leader in edge AI software, today announced the release of PySDK Enterprise, a commercial-grade software toolkit designed to streamline the development of edge AI applications.PySDK Enterprise provides a unified software stack that allows developers to integrate AI into

SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline Top-Line Results from Study Evaluating Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) Expected in First Quarter of 2026 GlobeNewswire August 05, 2025 DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Aug. 05, 2025 (GLOBE NEWSWIRE) — SynOx Therapeutics Limited (“SynOx”), a

Lingerfelt and The Davis Companies (Davis) are pleased to announce the recent signing of a 152,491 square foot lease with M.C. Dean at Carmel Church Business Center, located at 11174 Enterprise Parkway, Ruther Glen, VA 22546. Jake Servinsky and Jimmy Appich of JLL represented M.C. Dean and Graham Stoneburner and Mark Douglas of Cushman &

Second Quarter 2025 Highlights and Financial Results — Kristen Actis-Grande joining Sealed Air as Chief Financial Officer — Protective volumes further stabilized in the quarter with the industrial portfolio inflecting to volume growth driven by our continued transformation efforts — Food sales flat with favorable price offset by softer volume driven by market pressure in

Expanse's Venture Arm Launches with a Diverse Portfolio of Businesses on the Forefront of Enabling Technologies Powering the Future of Finance, Healthcare and Commerce Expanse, an asset management firm built with a family office perspective, is announcing their $18M Inaugural Fund alongside investments in a diverse portfolio of businesses on the forefront of enabling technologies

Q2 Highlights: — Revenue of $194.5 million — GAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2% — GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7% — GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13 Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial

Conference Call Scheduled for Monday, August 11, 2025, at 8:00 a.m. ET — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report second quarter 2025 financial results on Monday, August 11, 2025. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m.